All Articles

Explore Our Insights

Regulatory & Compliance 4 Sep 12 min read

Elemental Impurities (ICH Q3D) for API Buyers

Elemental impurities under ICH Q3D are controlled by a documented risk assessment, not by testing every metal in every lot. What API buyers must demand from suppliers, and why catalysts are the usual finding.

Contract R&D 3 Sep 13 min read

Biotech Startup Chemistry Budget: Seed to IND

A biotech chemistry budget from seed to IND is mostly back-loaded, and founders consistently underestimate the step-change at IND-enabling. Phase-by-phase ranges, what moves them, and the five mistakes that cost the most.

Procurement & Sourcing 1 Sep 12 min read

Agrochemical Intermediates Under New Trade Rules

Agrochemical intermediates sourcing carries thinner margins and a hard seasonal window pharma never faces. How to plan tariff exposure, EPA impact, and qualification around the spray season.

Drug Discovery 1 Sep 13 min read

Building Block Libraries: Buy, Build, or Commission?

Building block libraries for drug discovery come three ways: bought from catalog, built in house, or commissioned from a CRO. Honest economics, design principles, and a decision framework for each.

Custom Synthesis 29 Aug 12 min read

Custom Synthesis RFQ: What to Include

A complete custom synthesis RFQ gets a firm quote in 24 hours. An incomplete one starts a two-week email thread. Here is every field a chemist needs, and why each one changes the route.

Custom Synthesis 27 Aug 12 min read

ChemContract vs Large CDMOs: An Honest Comparison

ChemContract vs large CDMO is not a question with one answer. A candid comparison of where a mid-size specialist wins on speed and access, and where a top-tier CDMO is genuinely the better choice.

Custom Synthesis 26 Aug 13 min read

Custom Synthesis Pricing: What Drives Your Quote

Custom synthesis pricing is not a black box once you know which variables move it. Route length, overall yield, purification burden, analytical package and timeline drive most of the number — and a buyer can influence all five.

Procurement & Sourcing 25 Aug 14 min read

Chemical Sourcing Glossary: Terms Buyers Need

A chemical sourcing glossary organized by theme rather than alphabet, covering organization types, material grades, ICH shorthand, analytical terms, and the term pairs buyers most often conflate.

Custom Synthesis 23 Aug 13 min read

US-Based Custom Synthesis: A Capability Map

A buyer's map of US-based custom synthesis capability by chemistry type, not by vendor: when your molecule needs each one, how to verify a supplier really has it, and what a wrong answer costs.

Custom Synthesis 20 Aug 13 min read

Chiral Resolution vs Asymmetric Synthesis: Choosing a Route

Chiral resolution vs asymmetric synthesis is a scale and timeline decision, not a chemistry preference. A route-selection framework covering diastereomeric salts, DKR, chiral chromatography, asymmetric hydrogenation and chiral pool starting materials.

Procurement & Sourcing 20 Aug 12 min read

Section 232 Tariffs: Recalculating Landed Cost Per Kilogram

Section 232 tariffs changed landed cost per kilogram by HTS line, not by product category. A working method for rebuilding the model, including drawback, FTZ deferral, and qualification cost.

Supply Chain 18 Aug 12 min read

The Cost of a Failed Supplier: A Quantified Model

The cost of supplier failure in chemical procurement is understated because schedule cost never enters the model. Eight components, a worked example, and the arithmetic that justifies dual sourcing.

Regulatory & Compliance 17 Aug 12 min read

BIOSECURE Act: What It Means for Your Chemical Supply Chain

The BIOSECURE Act restricts named biotechnology providers, not a whole country. Here is who is actually in scope, how to run a supplier screen, and why the January 2032 deadline is a 2026 problem.

Supply Chain 14 Aug 13 min read

Pharmaceutical Supply Chain De-Risking: A Buyer's Framework

Pharmaceutical supply chain de-risking in 2026 means surviving BIOSECURE, Section 232 tariffs, and single-source concentration at once. A framework for mapping exposure, ranking it by real cost, and retiring it in a defined order.

Custom Synthesis 13 Aug 14 min read

CRO Buyer's Guide: Choosing a Chemistry Partner

A CRO buyer's guide to chemistry outsourcing: the CRO / CDMO / CMO distinction, the five buying situations, capability screening that works, and a weighted scorecard you can copy.

Custom Synthesis 11 Aug 12 min read

Cryogenic Chemistry at Minus 78 C: Cost and Why

Cryogenic chemistry at minus 78 C is the quote line that doubles a price. What really drives that cost at scale, which reactions need it, and when minus 40 C will do.

Custom Synthesis 6 Aug 12 min read

Flow Chemistry vs Batch: Which Does Your Molecule Need?

Flow chemistry vs batch is a decision, not an upgrade. Flow wins decisively on exothermic, hazardous, gas-liquid and photochemical steps. Batch wins on slurries, long reactions and one-off quantities.

Custom Synthesis 4 Aug 14 min read

Fluorination Chemistry: Routes and Safety

A working guide to fluorination chemistry routes — nucleophilic, electrophilic, trifluoromethylation — plus the HF safety realities that decide whether you run the step or buy the building block.

Custom Synthesis 30 Jul 14 min read

Heterocycle Synthesis at Scale: What Changes

Heterocycle synthesis at scale fails for reasons that never appear on the bench: exotherms, mixing, chromatography that will not scale, and regioisomers nobody chased at 100 mg. A ring-by-ring guide.

Custom Synthesis 28 Jul 12 min read

High-Pressure Hydrogenation: Capability Questions to Ask

Choosing a high-pressure hydrogenation CRO means asking about vessel certification, catalyst selectivity, and residual metal removal — the questions that separate balloon chemistry from real capability.

Regulatory & Compliance 23 Jul 12 min read

ICH Q13 Continuous Manufacturing: CDMO Readiness

ICH Q13 continuous manufacturing sets the expectations a filing must meet. This is how to tell whether a CDMO can actually support a Q13 submission or simply owns a flow reactor.

Drug Discovery 21 Jul 12 min read

Specialty Dyes and Fluorescent Probes: A Sourcing Guide

Fluorescent probes sourcing is a specification problem before it is a price problem. What excitation maxima, Stokes shift, brightness, dye content and reactive-derivative chemistry actually mean when you place the order.

Service Spotlight 26 May 18 min read

Process Chemistry: Lab to Pilot in 5 Stages

Process chemistry optimization in 5 stages: from route selection to validated pilot-plant production. Cost benchmarks and timelines included.

Custom Synthesis 23 May 16 min read

How to Choose a Custom Synthesis CRO: The Buyer's Evaluation Guide

A structured buyer's evaluation guide for R&D directors and procurement leads selecting a custom synthesis CRO — with weighted scoring matrix, RFP template, and warning signs to watch for in proposals.

Procurement & Sourcing 20 May 11 min read

2026 Tariffs on Pharmaceutical Chemicals: What Buyers Must Do Now

The April 2026 Section 301 escalation reset pharmaceutical chemical sourcing tariffs 2026 across APIs, intermediates, and reagents. A current-rates guide for procurement teams plus a 90-day diversification action plan.

Procurement 19 May 16 min read

Reference Standard Sourcing and Certification

Reference standard sourcing affects every analytical result. Learn certification requirements, vendor qualification, and when custom synthesis makes sense.

Procurement & Supply Chain 17 May 20 min read

Pharmaceutical Supplier Qualification: The Complete 2026 Checklist

A 40+ point chemical supplier qualification checklist for 2026 — covering FDA/ICH Q10 evidence, GMP audits, data integrity, supply-chain transparency, and a printable scorecard for procurement teams.

Custom Synthesis 14 May 13 min read

Oxetane Synthesis in Drug Discovery: From Scaffold Design to CRO Scale-Up

Oxetanes are one of the fastest-growing scaffold classes in drug design — small ring, big medicinal chemistry payoff. Here's how oxetane building blocks are made, where the synthesis traps live, and what to specify when outsourcing.

Chemical Industry 12 May 17 min read

CRO vs CDMO: Decision Framework

CRO vs CDMO outsourcing requires matching project stage to the right model. Use this framework to avoid costly development mismatches.

Drug Discovery 11 May 8 min read

Hit-to-Lead Chemistry: How Contract R&D Compresses Your Timeline

Hit-to-lead chemistry CRO engagement turns a confirmed HTS hit into a developable lead series weeks faster than internal medicinal chemistry alone. A practical guide to deliverables, timelines, and what to put in your brief.

Service Spotlight 8 May 14 min read

HPLC Method Development for APIs: When to Outsource to an Analytical CRO

When HPLC method development for an API is the bottleneck in your filing timeline, an analytical CRO can run scouting, optimization, validation, and transfer in parallel — here's when that's the right call.

Service Spotlight 5 May 16 min read

Custom Chemicals for Biotech Startups

Custom chemicals for biotech startups demand precise specs, IP protection, and the right partner. Source small-batch compounds without overpaying.

Contract R&D 5 May 14 min read

IND-Enabling Chemistry: What Early-Stage Biotechs Should Outsource to a CRO

A Series A biotech preparing an IND has roughly nine months of chemistry work to compress. Here's exactly what to outsource to an IND-enabling chemistry CRO and what should stay in-house.

Medicinal Chemistry 2 May 9 min read

Spirocyclic and Bicyclic Amine Synthesis: CRO Capabilities Explained

A practical guide to spirocyclic amine synthesis CRO selection — diazaspiro[4.4]nonane routes, bicyclic amine drug discovery considerations, and the capability checklist that separates discovery vendors from development partners.

Regulatory & Compliance 29 Apr 16 min read

cGMP Contract Manufacturing Requirements: A Pharma Buyer's Guide

A buyer-focused walkthrough of cGMP contract manufacturing requirements — 21 CFR 210/211, ICH Q7, IQ/OQ/PQ, batch records, and how to verify compliance before you sign.

Regulatory 28 Apr 18 min read

Impurity Profiling and Forced Degradation Guide

Impurity profiling and forced degradation studies underpin pharma regulatory submissions. Master ICH thresholds, study design, and methods.

Custom Synthesis 26 Apr 12 min read

Boronic Ester Synthesis for Drug Discovery: What Pharma CROs Deliver

Pinacol boronates and arylboronic acids power Suzuki-Miyaura coupling in drug synthesis. Here's how a well-equipped CRO designs, makes, and ships them at the scale and purity programs actually need.

Service Spotlight 21 Apr 16 min read

Contract R&D Labs Reduce Time-to-Market

Contract R&D labs compress chemical development timelines by 40-60% through parallel execution and specialized expertise. A practical guide.

Drug Discovery 14 Apr 17 min read

Combinatorial Chemistry Libraries for Drug Discovery

Combinatorial chemistry libraries accelerate drug discovery through scaffold selection, parallel synthesis, and ADMET-guided design.

Procurement 7 Apr 16 min read

API Intermediate Sourcing: Domestic vs Offshore

API intermediate sourcing decisions should be driven by total cost of ownership, not unit price. See why domestic wins.

Procurement 3 Apr 22 min read

The Complete Guide to Chemical Procurement in 2026

Chemical procurement guide for 2026: sourcing strategies, vendor qualification, cost optimization, and regulatory compliance for pharma buyers.

Procurement 31 Mar 17 min read

Chemical Supplier Qualification Checklist (2026 Free Template)

Chemical supplier qualification done right. Step-by-step audit checklists, risk frameworks, and KPIs for procurement managers.

Service Spotlight 24 Mar 18 min read

Outsourcing Analytical Testing for Pharma

Outsourcing analytical testing saves pharma companies 40-60% per test. Learn vendor qualification, turnaround benchmarks, and data integrity.

Regulatory 17 Mar 17 min read

GMP vs Non-GMP: When FDA Requires Each

GMP vs non-GMP manufacturing differs 3-5x in cost. Use this decision framework to choose the right compliance level for your project.

Procurement 10 Mar 16 min read

How to Choose a Custom Synthesis Partner

Choose the right custom synthesis partner using 8 critical evaluation criteria covering technical capability, quality systems, IP protection, and pricing.

Industry Trends 5 Feb 15 min read

Chemical Procurement Trends to Watch in 2026

US chemical buyers are shifting allocation toward domestic suppliers. Seven procurement trends shaping 2026, what is driving each, and a practical action checklist.

Industry Trends 8 Jan 15 min read

Green Chemistry in Contract R&D

Green chemistry in contract R&D reduces costs, waste, and regulatory risk. See how sustainable synthesis practices transform pharma manufacturing.

Supply Chain 11 Dec 15 min read

True Cost of International Chemical Sourcing 2026

International chemical sourcing hides costs that add 30-60% to unit price. See the full TCO breakdown favoring domestic suppliers.

Service Spotlight 20 Nov 14 min read

Scale-Up Challenges in Custom Synthesis

Scale-up challenges derail custom synthesis projects. Expert solutions for heat transfer, crystallization, safety, and process optimization.

Regulatory & Compliance 30 Oct 15 min read

GHS Labeling Requirements: Common Mistakes

GHS labeling errors cost organizations thousands in OSHA fines. Learn the most common mistakes and how to build a compliant labeling process.

Service Spotlight 9 Oct 15 min read

Combinatorial Chemistry in Drug Discovery

Combinatorial chemistry accelerates drug discovery through parallel library synthesis. Learn how modern automation shortens timelines from years to months.

Supply Chain 18 Sep 16 min read

Building a Resilient Chemical Supply Chain

Chemical supply chain resilience requires a practical framework. Learn how to build redundancy without sacrificing cost.

Service Spotlight 28 Aug 14 min read

Analytical Testing Methods for Pharma Buyers

Analytical testing methods help pharma buyers evaluate supplier quality, interpret certificates of analysis, and ensure chemicals meet specifications.

Industry Trends 7 Aug 15 min read

How AI Is Transforming Chemical Procurement in 2026

AI is reshaping chemical procurement in 2026. Discover what's delivering real ROI and what to implement now.

Service Spotlight 17 Jul 15 min read

Contract R&D vs. In-House Labs: Cost Analysis

Contract R&D vs. in-house labs — compare real costs, hidden expenses, and strategic trade-offs to find the right R&D model for your organization.

Regulatory & Compliance 26 Jun 15 min read

Navigating TSCA Compliance for Procurement

TSCA compliance is non-negotiable for chemical procurement. A practical guide to inventory verification, SNURs, and avoiding costly violations.

Service Spotlight 5 Jun 14 min read

Custom Synthesis: Milligram to Multi-Ton Scale

Custom synthesis spans milligram screening to multi-ton production. Learn about timelines, costs, and scale-up challenges at every stage.

Chemical Industry 13 May 14 min read

How Domestic Chemical Sourcing Boosts Profitability

Domestic chemical sourcing boosts profitability when you measure total cost of ownership. See the real numbers.

Chemical Industry 24 Apr 15 min read

Rethinking Chemical Procurement in 2025

Chemical procurement is shifting from cost-first to value-first. Learn why local sourcing is the new strategic advantage.

Chemical Industry 7 Mar 16 min read

The Tariff Trap in Global Chemical Sourcing

Tariff escalation reshaped the economics of global chemical sourcing. How duty stacking impacts landed cost, which categories are most exposed, and when domestic sourcing wins on total cost.

Chemical Industry 12 Feb 14 min read

Future of Chemical Procurement: 2025 to 2035

Chemical procurement from 2025 to 2035: carbon pricing, AI automation, circular chemistry, and what to invest in now.

Chemical Industry Intelligence

2027 Chemical Procurement Budget Framework